BioSpace News Archive

Onconova Therapeutics, Inc., a biopharmaceutical company focused on discovering and developing novel products to treat cancer, reported financial results for the quarter ended September 30, 2020 and provided a business update.

Recently completed capital raise expected to fully fund U.S. pivotal Phase 3 program, with topline results anticipated in Q4 2021

First patient dosed in Phase 2 study of ANX005 C1q targeted mAb

Agile Therapeutics, Inc., a women’s healthcare company, reported financial results for the three and nine months ended September 30, 2020 and provided a corporate update.

Completesenrollment of ATYR1923clinical trial in patients with COVID-19 severe respiratory complications.Topline data is expected at turn of calendar year.

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that the management team will present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020 at 12:30pm ET.

IntelGenx Technologies Corp. reported financial results for the third quarter ended September 30, 2020.

ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, announced unaudited financial results for the quarter ended September 30, 2020.

Yield10 Bioscience, Inc., an agricultural bioscience company, reported financial results for the three and nine months ended September 30, 2020.

Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced the appointment of pharmaceutical industry leader Paolo Pucci to its Board of Directors, effective immediately